Global Umbilical Cord Blood Banking Market: Overview
Umbilical cord blood, which is what remains in the placenta after birth, has life-saving properties. It finds application in the treatment of genetic or hematopoietic diseases. Applying latest cutting-edge technologies involving medical data-keeping and storage, cord blood banks allow individuals to store blood from the umbilical cord for later use. Cord blood banks are quite ubiquitous these days and can be both public and private. The banks usually charge a fee for collection in additional to an annual fee for maintenance and storage. The global cord blood banking services are supervised by bodies, namely the Human Tissue Authority, Clinical Laboratory Improvement Amendments, and the American Association of Blood Banks.
A report by Transparency Market Research throws light on important facets of the global market for umbilical cord blood banking. It furnishes a qualitative analysis of the growth drivers and restraints in the market and chronicles the prevalent trends in it. The report is a comprehensive collection of historical, current, and projected data about the market. It offers an assessment of where the market stands today and its future trajectory. The report also offers a detailed assessment of the competitive landscape and identifies key players contributing towards the growth of the market. Market-leading analytical tools have also be been leveraged to gauge the opportunities and threats awaiting players.
WideCells Group PLC (LON:WDC) blends a unique business model with an expert team to bring promising cord blood banking and stem cell therapy from the lab to the real world of family healthcare protection.
WideCells Group was founded to leverage that expertise to create a truly unique, wholly sustainable group of companies; complementing each other and all striving to positively shape the future of the industries we work in.